Valneva licenses Shigella vaccine candidate from LimmaTech

MLA

“Valneva Licenses Shigella Vaccine Candidate from LimmaTech.” M2 EquityBites (EQB), 1 Aug. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.803381139&authtype=sso&custid=ns315887.

APA

Valneva licenses Shigella vaccine candidate from LimmaTech. (2024, August 1). M2 EquityBites (EQB).

Chicago

M2 EquityBites (EQB). 2024. “Valneva Licenses Shigella Vaccine Candidate from LimmaTech,” August 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.803381139&authtype=sso&custid=ns315887.